Rankings
▼
Calendar
BCYC Q2 2020 Earnings — Bicycle Therapeutics plc Revenue & Financial Results | Market Cap Arena
BCYC
Bicycle Therapeutics plc
$360M
Q2 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$2M
+3.2% YoY
Gross Profit
$2M
100.0% margin
Operating Income
-$13M
-801.0% margin
Net Income
-$12M
-771.2% margin
EPS (Diluted)
$-0.67
QoQ Revenue Growth
+39.1%
Cash Flow
Operating Cash Flow
-$12M
Free Cash Flow
-$13M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$119M
Total Liabilities
$48M
Stockholders' Equity
$71M
Cash & Equivalents
$97M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$2M
$2M
+3.2%
Gross Profit
$2M
-$5M
+131.3%
Operating Income
-$13M
-$8M
-57.5%
Net Income
-$12M
-$10M
-18.6%
← FY 2020
All Quarters
Q3 2020 →